Niue Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Niue Health Report.

Press releases published on July 27, 2026

Jul. 27, 2026

Genvor’s Antimicrobial Peptides Advance into Sugar Beet Research

Indeterminate GlobeNewswire

Jul. 27, 2026

Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Michael H. Carrel to its Board of Directors

Indeterminate GlobeNewswire

Jul. 27, 2026

Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing

Indeterminate GlobeNewswire

Jul. 27, 2026

Kyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel

Indeterminate GlobeNewswire

Jul. 27, 2026

Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process

Indeterminate GlobeNewswire

Jul. 27, 2026

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.

Indeterminate GlobeNewswire

Jul. 27, 2026

Calidi Biotherapeutics Presents New Data on Cytotoxicity and IL-15 SA Expression in Human and Murine Tumor Cells at the American Association for Cancer Research Drug Discovery and Development Conference

Indeterminate GlobeNewswire

Jul. 27, 2026

Spero Therapeutics Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer

Indeterminate GlobeNewswire

Jul. 27, 2026

Humacyte Announces FDA Acceptance of IND for First-In-Human Clinical Study of CTEV for Coronary Artery Bypass Grafting

Indeterminate GlobeNewswire

Jul. 27, 2026

Oak Hill Bio and Research Alliance Corporation III Announce Business Combination Agreement to Create Publicly Listed Rare Disease Biotechnology Company to Advance Antisense Oligonucleotide Therapy Rugonersen for Angelman Syndrome

Indeterminate GlobeNewswire

Jul. 27, 2026

FLYTE Partners with 319 Golf Society and Named Exclusive Private Aviation Partner

Indeterminate GlobeNewswire

Jul. 27, 2026

Curium, in collaboration with nuclear cardiology leaders, announces immediate return of Thallous Chloride TI 201 Injection in the U.S. to support high-stakes cardiac imaging needs

Indeterminate GlobeNewswire

Jul. 27, 2026

Micron Biomedical Secures $4.5 Million Federal Contract to Develop First Dissolvable Microarray Radiation/Nuclear Medical Countermeasure

Indeterminate GlobeNewswire

Jul. 27, 2026

Eikon Therapeutics Announces First Patient Dosed in TeLuRide-008, a Registrational Phase 2/3 Trial of EIK1001 in Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire

Jul. 27, 2026

VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb

Indeterminate GlobeNewswire

Jul. 27, 2026

OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026

Indeterminate GlobeNewswire

Jul. 27, 2026

Tonix Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 10, 2026

Indeterminate GlobeNewswire

Jul. 27, 2026

Harrow To Report Second Quarter 2026 Financial Results After Market Close on August 10, 2026

Indeterminate GlobeNewswire

Jul. 27, 2026

Picard Medical Receives NYSE American Acceptance of Compliance Plan

Indeterminate GlobeNewswire

Jul. 27, 2026

Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026

Indeterminate GlobeNewswire